Dr. Hemali Vijay Tilva, MD

Dr. Tilva practices at Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University.

Dr. Tilva's NPI, 1881221190, was assigned on March 25, 2020. Dr. Tilva graduated from David Geffen School of Medicine at UCLA in 2020. Dr. Tilva holds California license A176903.

Dr. Tilva's primary practice is Stanford Health Care Tri-Valley, at 5555 West Las Positas Boulevard, Pleasanton, CA 94588 in Alameda County. The practice phone is (925) 847-3000.

Dr. Tilva's primary practice is Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University. Dr. Tilva is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Health Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tilva practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Tilva's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Tilva is board certified in internal medicine by the American Board of Internal Medicine. Dr. Tilva is licensed in California.

CMS data shows 853 Medicare services from Dr. Tilva across 4 procedure codes in 2024, for 345 Medicare patients. Medicare paid $89,081 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 345 Medicare patients who saw Dr. Tilva in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tilva's median patient age at 65, with 47% women.

In 2024, Dr. Tilva wrote 235 Medicare Part D claims for 100 patients. 90% of them were for generic drugs. CMS names the drug for 53 of them, across 4 drugs with 11 or more claims each, at $828 in total drug cost. In 2023, CMS named 298 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Tilva for performance year 2024, reported as part of a group. Dr. Tilva accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dr. Tilva graduated from David Geffen School of Medicine at UCLA in 2020.

Dr. Tilva is in network with 4 carriers, including Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.